Sharing a penny stock, HUMACYTE


A biotechnology company listed on the US stock market in 2021
Specializing in regenerative human organs and tissues, regenerative medicine
Simply put, it's about helping humans live longer
As the boss said, the goal is 150 years old
Their company's technology is very impressive
Products for vascular and non-vascular applications are critical globally
But biotechnology isn't in the AI hot topics
The entire sector hasn't been hyped up before
But it's worth a look, I think this stock is interesting
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned